Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 4/2020

01-04-2020 | Night-Blindness | Review

Ocular manifestations in celiac disease: an overview

Authors: Fotios S. Fousekis, Andreas Katsanos, Konstantinos H. Katsanos, Dimitrios K. Christodoulou

Published in: International Ophthalmology | Issue 4/2020

Login to get access

Abstract

Purpose

To review and highlight the ocular manifestations associated with celiac disease (CD) and presentation of their pathogenetic mechanisms.

Methods

A thorough review of the literature was performed using PubMed to identify articles about serrated polyposis syndrome. The search was performed using the search string: (“celiac disease” OR “coeliac disease”) AND (“ocular manifestations” OR “eye” OR “orbitopathy” OR “uveitis” OR “neuro-ophthalmic manifestations”). Only articles in English were reviewed.

Results

Several ocular symptoms and disorders have been associated with CD and are a result of defective intestinal absorption and immunological mechanisms. These include nyctalopia, dry eye, cataract, thyroid-associated orbitopathy, uveitis, central retinal vein occlusion and neuro-ophthalmic manifestations. In addition, CD-related ocular disease may represent the first manifestation of CD.

Conclusion

CD may hold accountable for the development of ocular diseases of obscure etiology.
Literature
1.
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE (2012) The prevalence of celiac disease in the United States. Am J Gastroenterol 107(10):1538–1544 (quiz 7, 45) PubMed
2.
Singh P, Arora S, Singh A, Strand TA, Makharia GK (2016) Prevalence of celiac disease in Asia: a systematic review and meta-analysis. J Gastroenterol Hepatol 31(6):1095–1101PubMed
3.
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA, American College of G (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108(5):656–676 (quiz 77) PubMedPubMedCentral
4.
Laurikka P, Nurminen S, Kivela L, Kurppa K (2018) Extraintestinal manifestations of celiac disease: early detection for better long-term outcomes. Nutrients 10(8):1015PubMedCentral
5.
Martins TG, Costa AL, Oyamada MK, Schor P, Sipahi AM (2016) Ophthalmologic manifestations of celiac disease. Int J Ophthalmol 9(1):159–162PubMedPubMedCentral
6.
Karatepe Hashas AS, Altunel O, Sevinc E, Duru N, Alabay B, Torun YA (2017) The eyes of children with celiac disease. J AAPOS 21(1):48–51PubMed
7.
Uzel MM, Citirik M, Kekilli M, Cicek P (2017) Local ocular surface parameters in patients with systemic celiac disease. Eye 31(7):1093–1098PubMedPubMedCentral
8.
Tokgoz Y, Terlemez S, Karul A (2018) Fat soluble vitamin levels in children with newly diagnosed celiac disease, a case control study. BMC Pediatr 18(1):130PubMedPubMedCentral
9.
Erdem T, Ferat C, Nurdan YA, Halime E, Muhammed Selcuk S, Hamza K et al (2015) Vitamin and mineral deficiency in children newly diagnosed with celiac disease. Turk J Med Sci 45(4):833–836PubMed
10.
Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA (2013) Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients 5(10):3975–3992PubMedPubMedCentral
11.
12.
Alwitry A (2000) Vitamin A deficiency in coeliac disease. Br J Ophthalmol 84(9):1079–1080PubMed
13.
Witherspoon SR, Callanan D (2008) Celiac disease presenting as a xerophthalmic fundus. Retina 28(3):525–526PubMed
14.
Chiu M, Dillon A, Watson S (2016) Vitamin A deficiency and xerophthalmia in children of a developed country. J Paediatr Child Health 52(7):699–703PubMed
15.
Apushkin MA, Fishman GA (2005) Improvement in visual function and fundus findings for a patient with vitamin A-deficient retinopathy. Retina 25(5):650–652PubMed
16.
McGeeney BE, Friedman DI (2014) Pseudotumor cerebri pathophysiology. Headache 54(3):445–458PubMed
17.
Hayes KC, McCombs HL, Faherty TP (1971) The fine structure of vitamin A deficiency. II. Arachnoid granulations and CSF pressure. Brain J Neurol 94(2):213–224
18.
Calhoun MC, Hurt HD, Eaton HD, Rousseau JE Jr, Hall RC Jr (1967) Rates of formation and absorption of cerebrospinal fluid in bovine hypovitaminosis A. J Dairy Sci 50(9):1489–1494PubMed
19.
Libien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y et al (2017) Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 372:78–84PubMed
20.
Dotan G, Goldstein M, Stolovitch C, Kesler A (2013) Pediatric pseudotumor cerebri associated with low serum levels of vitamin A. J Child Neurol 28(11):1370–1377PubMed
21.
22.
Raina UK, Goel N, Sud R, Thakar M, Ghosh B (2011) Bilateral total cataract as the presenting feature of celiac disease. Int Ophthalmol 31(1):47–50PubMed
23.
Sari R, Yildirim B, Sevinc A, Buyukberber S (2000) Idiopathic hypoparathyroidism and celiac disease in two patients with previous history of cataract. Indian J Gastroenterol 19(1):31–32PubMed
24.
Rickels MR, Mandel SJ (2004) Celiac disease manifesting as isolated hypocalcemia. Endocr Pract 10(3):203–207PubMed
25.
26.
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30(9):1738–1744PubMed
27.
Alzaben AS, Turner J, Shirton L, Samuel TM, Persad R, Mager D (2015) Assessing nutritional quality and adherence to the gluten-free diet in children and adolescents with celiac disease. Can J Diet Pract Res 76(2):56–63PubMed
28.
Reinken L, Zieglauer H (1978) Vitamin B-6 absorption in children with acute celiac disease and in control subjects. J Nutr 108(10):1562–1565PubMed
29.
Mooney PD, Kurien M, Evans KE, Rosario E, Cross SS, Vergani P et al (2016) Clinical and immunologic features of ultra-short celiac disease. Gastroenterology 150(5):1125–1134PubMed
30.
Post M, Lubinski W, Lubinski J, Krzystolik K, Baszuk P, Muszynska M et al (2018) Serum selenium levels are associated with age-related cataract. Ann Agric Environ Med 25(3):443–448PubMed
31.
Ajith TA (2015) Ranimenon. Homocysteine in ocular diseases. Clin Chim Acta 450:316–321PubMed
32.
Minassian DC, Mehra V, Jones BR (1984) Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet 1(8380):751–753PubMed
33.
Balasubramanian D, Bansal AK, Basti S, Bhatt KS, Murthy JS, Rao CM (1993) The biology of cataract. The Hyderabad cataract research group. Indian J Ophthalmol 41(4):153–171PubMed
34.
Mollazadegan K, Kugelberg M, Lindblad BE, Ludvigsson JF (2011) Increased risk of cataract among 28,000 patients with celiac disease. Am J Epidemiol 174(2):195–202PubMed
35.
36.
Roy A, Laszkowska M, Sundstrom J, Lebwohl B, Green PH, Kampe O et al (2016) Prevalence of celiac disease in patients with autoimmune thyroid disease: a meta-analysis. Thyroid 26(7):880–890PubMed
37.
Mormile R (2016) Celiac disease and Hashimoto’s thyroiditis: a shared plot? Int J Colorectal Dis 31(4):947PubMed
38.
39.
Ponto KA, Schuppan D, Zwiener I, Binder H, Mirshahi A, Diana T et al (2014) Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity. Clin Exp Immunol 178(1):57–64PubMedPubMedCentral
40.
Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S et al (2019) The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): review of the literature and report of a large series. Autoimmun Rev 18(3):287–292PubMed
41.
Kapoor A, Patwari AK, Kumar P, Jain A, Narayan S (2013) Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity. Indian J Pediatr 80(2):108–113PubMed
42.
Mikos H, Mikos M, Obara-Moszynska M, Niedziela M (2014) The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Polska 65(2):150–155
43.
Pras E, Neumann R, Zandman-Goddard G, Levy Y, Assia EI, Shoenfeld Y et al (2004) Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 34(3):602–609PubMed
44.
Klack K, Pereira RM, de Carvalho JF (2011) Uveitis in celiac disease with an excellent response to gluten-free diet: third case described. Rheumatol Int 31(3):399–402PubMed
45.
Krifa F, Knani L, Sakly W, Ghedira I, Essoussi AS, Boukadida J et al (2010) Uveitis responding on gluten free diet in a girl with celiac disease and diabetes mellitus type 1. Gastroenterol Clin Biol 34(4–5):319–320PubMed
46.
Hyrailles V, Desprez D, Beauerere L, de Ferrier F, Larrey D, Ramos J et al (1995) Uveitis complicating celiac disease and cured by gluten-free diet. Gastroenterol Clin Biol 19(5):543–544PubMed
47.
Mollazadegan K, Kugelberg M, Tallstedt L, Ludvigsson JF (2012) Increased risk of uveitis in coeliac disease: a nationwide cohort study. Br J Ophthalmol 96(6):857–861PubMed
48.
Rosenbaum JT, Lin P, Asquith M (2016) The microbiome, HLA, and the pathogenesis of uveitis. Jpn J Ophthalmol 60(1):1–6PubMed
49.
Weinstein JE, Pepple KL (2018) Cytokines in uveitis. Curr Opin Ophthalmol 29(3):267–274PubMed
50.
Casella G, Bordo BM, Schalling R, Villanacci V, Salemme M, Di Bella C et al (2016) Neurological disorders and celiac disease. Minerva Gastroenterol Dietol 62(2):197–206PubMed
51.
Arroyo HA, De Rosa S, Ruggieri V, de Davila MT, Fejerman N, Argentinean E et al (2002) Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in childhood. J Child Neurol 17(11):800–806PubMed
52.
Millington RS, James-Galton M, Barbur JL, Plant GT, Bridge H (2015) Severe, persistent visual impairment associated with occipital calcification and coeliac disease. J Neurol 262(9):2056–2063PubMed
53.
Wu D, Pardridge WM (1999) Blood-brain barrier transport of reduced folic acid. Pharm Res 16(3):415–419PubMed
54.
Masingue M, Benoist JF, Roze E, Moussa F, Sedel F, Lubetzki C et al (2019) Cerebral folate deficiency in adults: a heterogeneous potentially treatable condition. J Neurol Sci 396:112–118PubMed
55.
Bernasconi A, Bernasconi N, Andermann F, Dubeau F, Guberman A, Gobbi G et al (1998) Celiac disease, bilateral occipital calcifications and intractable epilepsy: mechanisms of seizure origin. Epilepsia 39(3):300–306PubMed
56.
Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D (2008) Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 64(3):332–343PubMed
57.
Johnson AM, Dale RC, Wienholt L, Hadjivassiliou M, Aeschlimann D, Lawson JA (2013) Coeliac disease, epilepsy, and cerebral calcifications: association with TG6 autoantibodies. Dev Med Child Neurol 55(1):90–93PubMed
58.
Patterson SL, Goglin SE (2017) Neuromyelitis optica. Rheum Dis Clin N Am 43(4):579–591
59.
Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6(7):383–392PubMed
60.
Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X et al (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17(8):1019–1032PubMed
61.
Jacob S, Zarei M, Kenton A, Allroggen H (2005) Gluten sensitivity and neuromyelitis optica: two case reports. J Neurol Neurosurg Psychiatry 76(7):1028–1030PubMedPubMedCentral
62.
Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G (2009) Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol 256(12):2097–2099PubMed
63.
Jarius S, Jacob S, Waters P, Jacob A, Littleton E, Vincent A (2008) Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4. J Neurol Neurosurg Psychiatry 79(9):1084PubMed
64.
Meyts I, Jansen K, Renard M, Bossuyt X, Roelens F, Regal L et al (2011) Neuromyelitis optica-IgG + optic neuritis associated with celiac disease and dysgammaglobulinemia: a role for tacrolimus? Eur J Paediatr Neurol 15(3):265–267PubMed
65.
Danielsson O, Lindvall B, Hallert C, Vrethem M, Dahle C (2017) Increased prevalence of celiac disease in idiopathic inflammatory myopathies. Brain Behav 7(10):e00803PubMedPubMedCentral
66.
Cerman E, Esen F, Eraslan M, Kazokoglu H (2014) Orbital myositis associated with celiac disease. Int Ophthalmol 34(3):635–638PubMed
67.
Katsanos A, Asproudis I, Katsanos KH, Dastiridou AI, Aspiotis M, Tsianos EV (2013) Orbital and optic nerve complications of inflammatory bowel disease. J Crohn’s Colitis 7(9):683–693
68.
Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D et al (2009) Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 15(1):29–34PubMed
69.
Lerner A, Blank M (2014) Hypercoagulability in celiac disease–an update. Autoimmun Rev 13(11):1138–1141PubMed
70.
Malhi RK, Dhami A, Malhi NS, Soni A, Dhami GS (2018) Central retinal vein occlusion revealing celiac disease: the first report of two cases from India. Indian J Ophthalmol 66(9):1315–1317PubMedPubMedCentral
71.
Jomni T, Bellakhal S, Abouda M, Abdelaali I, Douggui H (2015) An atypical presentation of celiac disease: central retinal vein occlusion. Pan Afr Med J 22:300PubMedPubMedCentral
72.
Lee ES, Pulido JS (2005) Nonischemic central retinal vein occlusion associated with celiac disease. Mayo Clin Proc 80(2):157PubMed
Metadata
Title
Ocular manifestations in celiac disease: an overview
Authors
Fotios S. Fousekis
Andreas Katsanos
Konstantinos H. Katsanos
Dimitrios K. Christodoulou
Publication date
01-04-2020
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 4/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-019-01254-x

Other articles of this Issue 4/2020

International Ophthalmology 4/2020 Go to the issue

Original Paper

Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients

Original Paper

Characteristics of ‘sawtooth shunt’ following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity

Original Paper

Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study

Original Paper

EDI-OCT choroidal thickness in Posner–Schlossman syndrome

Original Paper

Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center

Original Paper

Vitreous albumin redox state in open-angle glaucoma patients and controls: a pilot study